What is Curanex Pharmaceuticals Inc Common Stock (CURX) stock price today?

Curanex Pharmaceuticals Inc Common Stock (CURX) currently trades at $0.42 per share. The stock has a market capitalization of $12.38M and a P/E ratio of —x.

Is CURX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Curanex Pharmaceuticals Inc Common Stock has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is —.

Is Curanex Pharmaceuticals Inc Common Stock financially healthy?

Curanex Pharmaceuticals Inc Common Stock's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of — places it in the —.

CURX

Curanex Pharmaceuticals Inc Common Stock

NASDAQ: CURX · HEALTHCARE · BIOTECHNOLOGY

$0.42

+0.72% today

Updated 2026-04-30

Market cap

$12.38M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.02

Dividend yield

—

52W range

$0 – $9

Volume

5.3M

Market cap

$12.38M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.02

Dividend yield

—

52W range

$0 – $9

Volume

5.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-857404.00

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$26000.00	$0.00	$0.00	$0.00	$0.00
Net income	$-20233.00	$-19198.00	$-361506.00	$-4.23M	$-3.07M
EPS	—	—	—	—	$-0.02
Free cash flow	$3336.00	$-120.00	$-555580.00	$-10.48M	$-857404.00
Profit margin	-77.82%	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CURX	$12.38M	23	4.3	3.0	5.0	7.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Curanex Pharmaceuticals Inc Common Stock trades at $0.42. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Curanex Pharmaceuticals Inc Common Stock's stock price?

Curanex Pharmaceuticals Inc Common Stock (CURX) trades at $0.42.

Is Curanex Pharmaceuticals Inc Common Stock overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Curanex Pharmaceuticals Inc Common Stock (CURX)?

The analyst target price is $—, representing NaN% downside from the current price of $0.42.

Piotroski F-Score?

3/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-85.30%

Beta—

50D MA$0.42

200D MA$1.08

Shares out0.03B

Float0.01B

Short ratio—

Avg volume5.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CURX vs LLY →CURX vs JNJ →CURX vs ABBV →Stock screener →